Charles Duncan's Stock Ratings

Piper Sandler Analyst

Charles Duncan is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 09/06/2024

Overall Average Return

23.2%

Smart Score

73.2%

Overall Average Return Percentile

83rd

Number of Ratings

178
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

Expert Ratings For Intra-Cellular Therapies
This Robinhood Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday
Unveiling 14 Analyst Insights On Axsome Therapeutics
Evaluating Neurocrine Biosciences: Insights From 15 Financial Analysts
A Closer Look at 12 Analyst Recommendations For Jazz Pharmaceuticals
Deep Dive Into Intra-Cellular Therapies Stock: Analyst Perspectives (9 Ratings)
A Glimpse Into The Expert Outlook On Axsome Therapeutics Through 9 Analysts
Decoding 11 Analyst Evaluations For Jazz Pharmaceuticals
A Closer Look at 7 Analyst Recommendations For Neurocrine Biosciences
A Closer Look at 11 Analyst Recommendations For Intra-Cellular Therapies
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free